L’Oreal SA:企業のM&A・事業提携・投資動向

◆英語タイトル:L'Oreal SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C1094
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:115
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:消費財
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

L’Oreal SA – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s L’Oreal SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by L’Oreal SA since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes L’Oreal SA’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by L’Oreal SA. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on L’Oreal SA’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by L’Oreal SA and its subsidiaries since 2007.
- Information about key financial and legal advisors for L’Oreal SA’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about L’Oreal SA’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 6
LIST OF FIGURES 6
TARGETS AND PARTNERS 7
MERGERS & ACQUISITIONS 8
Mergers and Acquisitions – Overview 8
Mergers and Acquisitions – Deal reports 9
CORPORATE VENTURING 60
Corporate Venturing – Overview 60
Corporate Venturing – Deal reports 61
PARTNERSHIP 72
Partnership – Overview 72
Partnership – Deal reports 73
DIVESTMENTS 83
Divestments – Overview 83
Divestments – Deal reports 84
APPENDIX 105
Contact Us 105
About MarketLine Financial Deals Database 105
Deal Definition and Methodology 107
About MarketLine 114

List of Tables
Table 1: L'Oreal S.A. M&A volume and value trend (2014-YTD2018)
Table 2: L'Oreal S.A. M&A activity by geography (2014-YTD2018)
Table 3: L'Oreal S.A. corporate venturing volume and value trend (2014-YTD2018)
Table 4: L'Oreal S.A. corporate venturing by geography (2014-YTD2018)
Table 5: L'Oreal S.A. partnership volume and value trend (2014-YTD2018)
Table 6: L'Oreal S.A. partnership trend by key deal type (2014-YTD2018)
Table 7: L'Oreal S.A. divestments volume and value trend (2014-YTD2018)
Table 8: L'Oreal S.A. divestments activity by geography (2014-YTD2018)

List of Figures
Figure 1: L'Oreal S.A. M&A volume and value trend (2014-YTD2018)
Figure 2: L'Oreal S.A. M&A activity by geography (2014-YTD2018)
Figure 3: L'Oreal S.A. corporate venturing volume and value trend (2014-YTD2018)
Figure 4: L'Oreal S.A. corporate venturing by geography (2014-YTD2018)
Figure 5: L'Oreal S.A. partnership volume and value trend (2014-YTD2018)
Figure 6: L'Oreal S.A. partnership trend by key deal type (2014-YTD2018)
Figure 7: L'Oreal S.A. divestments volume and value trend (2014-YTD2018)
Figure 8: L'Oreal S.A. divestments by geography (2014-YTD2018)

★海外企業調査レポート[L’Oreal SA:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • SYNNEX Corp (SNX):企業の財務・戦略的SWOT分析
    SYNNEX Corp (SNX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Goldman Sachs Private Wealth Management:企業の戦略・SWOT・財務分析
    Goldman Sachs Private Wealth Management - Strategy, SWOT and Corporate Finance Report Summary Goldman Sachs Private Wealth Management - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • WABCO Holdings Inc.:企業の戦略・SWOT・財務分析
    WABCO Holdings Inc. - Strategy, SWOT and Corporate Finance Report Summary WABCO Holdings Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Orange SA:企業の戦略・SWOT・財務情報
    Orange SA - Strategy, SWOT and Corporate Finance Report Summary Orange SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Fonterra Co-operative Group Ltd:企業の戦略・SWOT・財務情報
    Fonterra Co-operative Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Fonterra Co-operative Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Beijing SL Pharmaceutical Co Ltd (002038)-製薬・医療分野:企業M&A・提携分析
    Summary Beijing SL Pharmaceutical Co Ltd (SL Pharma), formerly Beijing BaiLuyuan Bio-Pharmaceutical Co., Ltd is a bio-pharmaceutical company that develops and markets gene engineering drugs. The company offers products in the field of oncology, organ transplantation, wound management, cardivascular, …
  • Astrazeneca Pharma India Ltd (ASTRAZEN):企業の財務・戦略的SWOT分析
    Summary AstraZeneca Pharma India Ltd (AstraZeneca), a subsidiary of AstraZeneca Plc, is a biopharmaceutical company. It discovers, develops, supplies and commercializes medicines. The company’s product portfolio include Forxiga, Imdur, Crestor, Tagrisso, Lynparza, Betaloc, Symbicort, budesonide, for …
  • GOBARTO S.A.:企業の戦略・SWOT・財務情報
    GOBARTO S.A. - Strategy, SWOT and Corporate Finance Report Summary GOBARTO S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Applebee’s Restaurants LLC:戦略・SWOT・企業財務分析
    Applebee's Restaurants LLC - Strategy, SWOT and Corporate Finance Report Summary Applebee's Restaurants LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • KDDI Corporation:企業の戦略・SWOT・財務情報
    KDDI Corporation - Strategy, SWOT and Corporate Finance Report Summary KDDI Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Fri-El Green Power SpA-エネルギー分野:企業M&A・提携分析
    Summary Fri-El Green Power SpA (Fri-El) is a renewable energy company that offers production of electric energy from renewable sources. The company develops, builds and manages power stations fuelled with biogas. Its wind energy is produced through wind turbine generators that convert wind to kineti …
  • Phenex Pharmaceuticals AG-製薬・医療分野:企業M&A・提携分析
    Summary Phenex Pharmaceuticals AG (Phenex) is a drug discovery and development company that offers nuclear receptors for the development of novel therapies. The company offer services which include contract screening services, NR selectivity screening and SNuRM profiling to pharmaceutical, biotechno …
  • ChemImage Corp:企業の製品パイプライン分析
    Summary ChemImage Corp (ChemImage) is a molecular chemical imaging company that provides hyperspectral imaging technologies. The company develops molecular chemical imaging devices and data fusion tools for anatomic structure imaging, cancer detection and cardiovascular health assessment. It offers …
  • Kumba Iron Ore Ltd:企業の戦略・SWOT・財務情報
    Kumba Iron Ore Ltd - Strategy, SWOT and Corporate Finance Report Summary Kumba Iron Ore Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Biogen Inc (BIIB)-製薬・医療分野:企業M&A・提携分析
    Summary Biogen Inc (Biogen) is a global biotechnology company that manufactures and markets drugs for the treatment of neurodegenerative diseases and rare and autoimmune disorders. Its marketed products include Avonex (interferon beta-1a), Tysabri (natalizumab), Tecfidera (dimethyl fumarate), Zinbry …
  • Tesaro Inc (TSRO)-製薬・医療分野:企業M&A・提携分析
    Summary Tesaro Inc (Tesaro) is an oncology-focused biopharmaceutical company that focuses on developing in-licensed, oncology-related product candidates, comprising rolapitant, niraparib, and the product candidates under its immuno-oncology platform. VARUBI, the company’s first commercial product is …
  • Cyxone AB-製薬・医療分野:企業M&A・提携分析
    Summary Cyxone AB (Cyxone) is a biopharmaceutical company that develops cyclotide drugs for immune-related diseases. The company’s lead product include T20K, a compound to inhibit pro-inflammatory cytokines, such as IL2 that helps to reduce clinical symptoms in an animal model for multiple sclerosis …
  • Latvenergo AS-エネルギー分野:企業M&A・提携分析
    Summary Latvenergo AS (Latvenergo) is a state-owned power supply utility company that generates and supplies electricity and thermal energy, distributes electricity, leases transmission system assets. It generates electricity through various renewable energy sources such as hydropower, biomass, wind …
  • Electrical Geodesics Inc:企業の製品パイプライン分析2018
    Summary Electrical Geodesics Inc (EGI) is a medical device company that designs, develops and commercializes non-invasive neuro diagnostic products used to monitor and interpret brain activity. The company offers clinical products such as geodesic EEG system 400 series, spike detection software, geo …
  • GraceKennedy Ltd (GK):企業の財務・戦略的SWOT分析
    GraceKennedy Ltd (GK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆